WNBA Partners with Opill to Promote Over-the-Counter Birth Control Access

The multi-year partnership aims to educate and engage on reproductive health, with a focus on college campuses and social justice initiatives.

The WNBA and Opill, a non-prescription birth control pill, announced a partnership to enhance reproductive health access and education.
Opill is the first daily oral contraceptive available without a prescription in the U.S., following FDA approval last year.
The partnership will debut at the 2024 WNBA Draft and includes educational programs on college campuses nationwide.
The WNBA's social justice priorities for the season include civic engagement and reproductive health advocacy.
The collaboration also aims to integrate into the health equity work championed by WNBA players.